Introduction:Basic information about CAS 959610-30-1|Myristoyl Pentapeptide-17, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Myristoyl Pentapeptide-17 |
|---|
| CAS Number | 959610-30-1 | Molecular Weight | 796.14 |
|---|
| Density | 1.1±0.1 g/cm3 | Boiling Point | 1071.6±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C41H81N9O6 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 601.9±34.3 °C |
|---|
Names
| Name | Myristoyl Pentapeptide-17 |
|---|
| Synonym | More Synonyms |
|---|
Myristoyl Pentapeptide-17 BiologicalActivity
| Description | Myristoyl pentapeptide-17 can stimulate eyelash growth by stimulating keratin production. Myristoyl pentapeptide-17 promotes the delivery of key ingredients in the serum, such as the growth factors and lysophosphatidic acid[1]. |
|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
|---|
| References | [1]. Sachdev M, et al. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum. J Clin Aesthet Dermatol. 2020 Feb;13(2):61-66. Epub 2020 Feb 1. |
|---|
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|
| Boiling Point | 1071.6±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C41H81N9O6 |
|---|
| Molecular Weight | 796.14 |
|---|
| Flash Point | 601.9±34.3 °C |
|---|
| Exact Mass | 795.630981 |
|---|
| PSA | 266.65000 |
|---|
| LogP | 3.89 |
|---|
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
|---|
| Index of Refraction | 1.510 |
|---|
| InChIKey | NFPWMUOQSJXGGZ-ZZTWKDBPSA-N |
|---|
| SMILES | CCCCCCCCCCCCCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(N)=O |
|---|
Synonyms
| Myr-Lys-Leu-Ala-Lys-Lys-NH2 |
| N2-(1-Oxotetradecyl)-L-lysyl-L-leucyl-L-alanyl-L-lysyl-L-lysinamide |
| L-Lysinamide, N-(1-oxotetradecyl)-L-lysyl-L-leucyl-L-alanyl-L-lysyl- |
| N-Tetradecanoyl-L-lysyl-L-leucyl-L-alanyl-L-lysyl-L-lysinamide |
| N-((5S,8S,11S,14S,17S)-1,21-diamino-8-(4-aminobutyl)-5-carbamoyl-14-isobutyl-11-methyl-7,10,13,16-tetraoxo-6,9,12,15-tetraazahenicosan-17-yl)tetradecanamide |